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Here we propose a simple statistical algorithm for rapidly scoring loci associated with disease or
traits due to recessive mutations or deletions using genome-wide single nucleotide polymorphism
genotyping case–control data in unrelated individuals. This algorithm identiﬁes loci by deﬁning
homozygous segments of the genome present at signiﬁcantly different frequencies between cases
and controls. We found that false positive loci could be effectively removed from the output of this
procedure by applying different physical size thresholds for the homozygous segments. This
procedure is then conducted iteratively using random sub-datasets until the number of selected loci
converges. We demonstrate this method in a publicly available data set for Alzheimer0s disease and
identify 26 candidate risk loci in the 22 autosomes. In this data set, these loci can explain 75% of the
genetic risk variability of the disease.
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Introduction
Advances in whole-genome single nucleotide polymorphism
(SNP) assay technology have provided a powerful array of
tools for simultaneously scoring common genetic variation.
However, it is often difﬁcult to identify loci associated with
diseasebecauseofthelargenumberoftestscarriedoutandthe
associated conservative multiplicity adjustment, such as
Bonferroni method. We are interested in identifying such loci
associated with a disease likely due to recessive mutation or
gene deletions.
High density SNP analysis readily reveals the presence of
largehomozygous segments in unrelatedsubjects (Hinds et al,
2005; Simon-Sanches et al, 2007; Wang et al, 2007). The
probability of a randomly selected SNP locus being homo-
zygous(‘AA’or‘BB’)basedondatafromHapMapisabout0.65
(Hinds et al, 2005; Rabbee and Speed, 2006) and this may
lend itself to autozygosity mapping in ostensibly outbred
populations; however, traditional autozygosity mapping
methods (Lander and Botstein, 1987; Mueller and Bishop,
1993; Gschwend et al, 1996) based on consanguineous
relationships are not appropriate for unrelated individuals.
Toidentify lociwith possiblerecessiveeffectsofrelativelyhigh
penetrance in outbred populations, large sample sizes are
needed for genotyping. Some recent studies on homozygosity
analysis of SNP assays have been attempted using different
approaches (Woods et al, 2004; Lencz et al, 2007; Miyazawa
et al, 2007). However, they either have some familial relation-
shiprequirements(Woodsetal,2004;Miyazawaetal,2007)or
a high false positive rate (Lencz et al, 2007).
In the context of SNP genotyping, it is often not easy to
distinguishheterozygousgenomicdeletionfromhomozygosity;
thus a segment with all loci genotyped being ‘AA’ or ‘BB’ in a
pedigree genotype ﬁle could be either a region of genuine
homozygosity or effective hemizygosity caused by genomic
deletion. We callsucha region ‘apparently homozygous region’
(AH). By carrying out an appropriate association analysis on
AHs, one can detect not only the possible recessively mutated
loci from some common ancestor but also deletions (Hunter,
2005; Klein et al, 2005; Van Eyken et al, 2007).
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www.molecularsystemsbiology.comIn this paper, we propose a simple statistical algorithm for
genome-wide AH analysis (GAHA) of case–control data in
unrelated subjects. It can robustly identify loci that are
associated with disease by efﬁciently removing false positive
loci. We demonstrate this method in a publicly available data
set for Alzheimer’s disease (AD) (Coon et al, 2007), consisting
502627 SNP loci genotyped in unrelated 859 cases and 552
neurologically normal controls. A total of 26 loci from the 22
autosomes are identiﬁed and they explain 75% of the genetic
risk variability of the disease.
Results and discussion
AH size threshold
In the context of the current data, it is not appropriate to use
the number of loci as a measure of AH size as previously
reported (Lencz et al, 2007) because of its dependence on SNP
density. Here we use the number of nucleotide basepairs
betweentheﬁrstandlastlociofanAHasameasureofAHsize.
Let C be a size threshold of AHs. We are interested in
identifying loci proportions of which are signiﬁcantly different
between controls and cases in AHs with sizes XC. As seen in
Figure 1, for example, there are n1 cases and with a given C we
counttheproportionofthelocusSNP-1onAHsp1¼(numberof
AHs containing SNP-1)/n1. Similarly, for n0 controls, we ﬁnd
the proportion p0 of the same locus. Using p1 and p0,w e
compute z-statistic for proportional test as described in
Materials and methods. The locus is selected for further
screening if |z|Xz1 a/2, where a is the level of signiﬁcance.
The test statistic z follows a standard normal distribution
asymptoticallyas n0 andn1 increasewith each greater than 30.
We investigated the power for selecting loci based on a,A H
percentage differencebetween cases and controls,andAH size
threshold C through simulation. The relationships between z
value and AH percentage difference with various C are shown
inSupplementaryFigure1.Atasigniﬁcance levela¼0.001, the
powers to detect candidate loci were computed accordingly.
We deﬁne that a candidate locus is detectable if the
power40.8. Our results showed that at a signiﬁcance level
a¼0.001, we could detect a locus on AHsXC with a difference
of 30% between cases and controls using C¼10kb, or only of
7% using C¼1Mb.
On the basis of above signiﬁcance level a and a moderate C
value,typicallythousandsoflocicouldbeselected withalarge
false positiverate from data of unrelated subjects. A keystep is
to efﬁciently remove these falsely associated loci from the
candidate list. If we knew the minimum size of risk loci, then
we would set it as C and consider only AHXC, leading to a
lower false positive rate. However, such a C value is unknown.
OneapproachistousemultiplevaluesofCasdiscussedbelow.
In convention, deﬁne C¼1 for considering AHs with size X1.
Algorithm for screening risk loci
We propose to use multiple C values for screening risk loci.
Suppose we choose C1 and C2, with C1oC2, for selecting
candidate loci with |z|Xz1 a/2. It should be noted that the
distance between C1 and C2 must be larger than the minimum
distance between loci of the platform and may be chosen by
referring to some public genotyping parameters (for example,
the average distance between loci is B9kb in Affymetrix
500K GeneChip, and a median distance is B3kb in Illumina
HumanHap550 BeadChip according to Gunderson et al, 2005;
Steemers and Gunderson, 2007). Let S1 be the set containing
the loci selected with C1 and S2 with C2, respectively. As the
true AHs with size XC24C1 will remain using either C1 or C2,
the loci, not in S1
T
S2, should be more likely false positives
and thus be removed. For example, in the AD data using a
signiﬁcance level a¼0.001, among the 25086 loci on chromo-
some 1, there were 18 loci selected using C¼10kb and 12 loci
using C¼30kb, respectively, with only three being common
loci in both sets. In general, we set C¼{Ci,i ¼1, 2,y, L} with
C1oC2oyoCL to cover a wide range of AHs and let S be the
set containing all loci common in adjacent sets S¼{S1
T
S2,
S2
T
S3,y, SL 1
T
SL}. This loci-selecting procedure is called
‘procedure of adjacent-C-selection’ (PACS).
ThePACScanefﬁcientlyremovefalsepositiveloci,however,
for a real data set in unrelated individuals with large genetic
variation, the selected loci usually still contain some false
positives, many of which could be removed through further
‘puriﬁcation’. To achieve this, ideally we should repeat the
above steps using an independent data set from the same
population to get another candidate set. Then identify the
common loci from both sets. This new candidate set contains
fewer false positive loci, which could be further removed by
repeating above steps iteratively until the number of candidate
loci converges. Although it is generally not realistic to do so,
we could do the ‘puriﬁcation’ using random subsets from the
full data set as described below.
Let nk*¼[f nk]430 be the size of a random subset
from the full data set of size nk, where k¼1 for cases and
k¼0 for controls, and f be a constant with 0ofofmax,
fmax ¼ð mink ðnkÞ 1Þ=mink ðnkÞ. The randomly and indepen-
dently chosen n1* cases and n0* controls form a random case–
control sub-data set for further removing the false positive loci
Figure 1 Scheme for computing the proportion of a locus on AHs. For a
given chromosome of a subject, the symbols (K, J) represent SNP loci. The
shaded segments denote AHs with size greater than or equal to a pre-selected
threshold C. The proportion of a locus on AHs is computed as p¼ (the number of
AHs containing this locus)/(the total number of individuals), for example p1¼4/6
for SNP-1.
Algorithm for genome-wide homozygosity analysis
W Liu et al
2 Molecular Systems Biology 2009 & 2009 EMBO and Macmillan Publishers LimitedfromthecandidatesetusingthesamesetofCvaluesasapplied
to the full data set.
Let S be the set containing the selected loci fromthe full data
set and S* be that from the ﬁrst random sub-data set. Let
S1*¼S*
T
S containing the common loci in both sets and
N1¼|S1*| be the number of loci in S1*. Next we generate a new
S* from the second random sub-data set and let S2*¼S1*
T
S*
with N2¼|S2*|. Repeating these steps to update the candidate
loci set until the number of Nt, t¼1,2,yyy, converges to a
constant integer Nc with Nc ¼0 if the null hypothesis of no
differencebetweenp1andp0istrueandNc40ifthealternative
hypothesis p1ap0 is true. For a given f, there are
n0
½f n0 
  
 
n1
½f n1 
  
possible ways for selecting case–control subset, which should
be much larger than the number required for reaching
convergence at an appropriate level of signiﬁcance. The above
GAHA algorithm is summarized in Box 1.
Box 1 Outline of the GAHA algorithm
(1) For case–control SNP data with n1 cases and n0 controls, choose a level of signiﬁcance a, set AH thresholds C¼{Ci, i¼1, 2,y, L} with
C1oC2oyoCL, and then ﬁnd AHs with size Ci, i¼1, 2,y, L, for each subject
(2) Compute z at each locus and select it if |z|Xz1-a/2. Perform the PACS and let Sold be the set of selected loci and Nold¼|Sold|.
Chose 0ofominkðnkÞ 1=minkðnkÞ, and c¼0
(3) Randomly select a case–control sub-dataset from (1) with n1* ¼ [f n1] 430 cases and n0* ¼ [f n0] 430 controls. Find AHs for each
subject at given C, then compute z at each locus and select it if |z|X z1-a/2
(4) Carry out the PACS and let S* be the set containing all the loci selected from the sub-dataset. Find
Snew¼Sold
T
S*
Nnew¼|Snew|
(5)
IfNnew ¼¼ Nold
Yes ! stop
No ! letSold ¼ Snew;Nold ¼ Nnew;‘¼‘ þ 1;thenGOTOð3Þ
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Figure 2 The plot of z versus nucleotide basepair of chromosome 19 in the AD data set: (A) before and (B) after the procedure of adjacent-C-selection, (C) the most
signiﬁcant region—the peak locus is rs4420638, (D) the most signiﬁcant region with two loci on APOE (k).
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pa. The false negative rates of loci selection in a random
subset were estimated under the same settings for the full data
set (Supplementary Table 2).
Application to AD data set
Set C¼{1, 10kb, 30kb, 50kb, 100kb, 140kb, 250kb, 500kb,
1Mb} and a¼0.001. We identiﬁed 607 loci from 4054 loci
whose |z|Xz1 a/2 (Figure 2A) from the 22 autosomes in the
AD data set (Coon et al, 2007).
The most signiﬁcant AH region was on 19q13.2 (see
Figure 2B) with positive z values suggesting signiﬁcantly more
AHs in controls than in cases. This region, covering the whole
apolipoprotein E (APOE) gene, contains four loci including
rs4420638 (Figure 2C), which is in linkage disequilibriumwith
APOE (Coon et al, 2007). However, there were no genotypes
within APOE in the AD data. We added available genotyping
information (Coon et al, 2007) of two loci on APOE, rs429358
and rs7412, to the AD data. The two APOE loci deﬁne the e2/
e3/e4 genotypes. Figure 2D shows the APOE loci indeed on the
AH region where the majority controls have the e3 genotype,
supporting the observation that APOE e3 is protective against
the disease when compared with e4 (Farrer et al, 1997).
To further reduce the false positive rate within this list, we
chose f¼0.9 for generating random subsets, each with 773
cases and 497 controls. The use of f¼0.9 may not be the
statistically optimal choice; it is, however, the best we tried.
The convergence of the loci number is shown in Figure 3.
There were 26 loci in the ﬁnal list (Figure 3B) (Table I). Based
on a logistic regression model ﬁt, the percent variation of the
genetic risk explained by these 26 loci was 75.3%. Model
selection removed 10 confounder loci and retained 16 loci
(each with P-valueo0.05), including rs4420638, in the
reduced model with 74.8% of the genetic risk variation
explained (Supplementary Table 3, 4).
The APOE e4 was carried by B40% of the later-onset AD
cases(Poirieretal,1993;Lawsetal,2003).Recallthatrs4420638
is in linkage disequilibrium with APOE, we found that the
percent genetic risk variation explained by this locus alone was
34.2%. However, when rs4420638 was excluded from the
reduced model, the percentage genetic risk variation explained
by the remaining 15 loci was decreased only by 2.9% (from
74.8% to 71.9%). This suggests these loci explain the genetic
riskvariationofADasagroup.Severalofthe26lociidentiﬁedin
thisscreeningwerealsofoundinhomozygousregionsidentiﬁed
in an early onset AD study of a consanguineous family
(Clarimo ´n et al, 2008), suggesting that one of these regions
harbors a recessive genetic lesion causing AD.
The 26 loci are on 20 genes of which 13 are in known
functional pathways or networks as revealed from an
Ingenuity Pathway Analysis (Ingenuity Systems, www.
ingenuity.com) (Supplementary Pathway/Network analysis).
On the basis of the correlations among the 20 genes and AD
status of subjects, we construct an AD genetic network
(Supplementary Figure 2).
Summary
We propose a statistical method for GAHAof SNPcase–control
data in unrelated subjects to identify risk loci that are most
likelyassociatedwithadiseaseorabnormalityduetorecessive
mutation or deletion. The main novelty of this method over
other approaches is to minimize the false positive rate of the
risk candidates. We remove the false positive loci by selecting
the common loci with different size thresholdsof homozygous
segments and repeating these steps iteratively using random
sub-data sets until the number of selected loci converges.
Furthermore, this method allows selects risk loci from a wider
AH size range. By demonstrating of the method using a
publicly available AD SNP assay data set, we identiﬁed 26
candidate risk loci from the 22 autosomes.
Materials and methods
Notes
Suppose there are n SNP loci genotyped on a given chromosome (an
autosome). We view the sequences of SNP loci on a chromosome as
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Figure 3 Convergence of the loci number. (A) At a level of signiﬁcance
a¼0.001, a total of 607 loci (&) were selected from the 4054 loci for which |z|X
z1 a/2 (D) by applying the procedure of adjacent-C-selection in the AD data set.
Random case–control subsets were generated using f¼0.9 and used in
screening iteration (J). (B) The enlarged plot showing the convergence of
selected loci to the number 26.
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thatH¼{h1,h 2,y,h m}wherehidenotesthenumberofAHscontaining
i consecutive SNP loci genotyped, and m is the maximum number of
consecutive SNP loci. The probability of a randomly selected SNP
locus on AHs with SNP number being equal to or larger than a
predetermined integer k is Pk ¼ PðXXkÞ¼ 1
n
Pm
i¼kihi.
Data
A SNP genotype data set of late-onset AD(500K Affymetrix)
was downloaded from a publicly available website, http://www.
neuron.org, to demonstrate our method. This data set consists of
502627 SNP loci genotyped in unrelated 859 cases and 552
neurologically normal controls.
Proportion test
We are interested in identifying loci at which the proportion of a SNP
locus, on AHs with size equal to or larger than a given threshold C,i s
signiﬁcantly different between controls and cases. Our null hypothesis
is that the SNP at a given locus has the same probability of being on
AHs with size XC in the control and case groups. The test statistic in a
standard proportion test is
z ¼
p0   p1 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
 pð1    pÞ 1
n0 þ 1
n1
   r with  p ¼
n0p0 þ n1p1
n0 þ n1
ð1Þ
and follows a Gaussian distribution under the null hypothesis,
where the p0 is the proportion of the locus on AHs for the n0 control
subjects and the p1 is that for the n1 cases. We deﬁne z¼0 when both
p0¼0 and p1¼0. For a given level of signiﬁcance a, a locus is selected if
|z|Xz1 a/2. This test requires large sample size (n0, n1430).
Logistic regression
In logistic regression using the selected loci as predictor variables, let
xij¼1if the ith locusof the jth subjectis on an AH with sizebeing equal
to or larger than C¼10kb and xij¼0 otherwise. Logistic regression is
carried out using SAS 9.0.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
Declaration
The views expressed in this article do not represent those of the US
Food and Drug Administration.
Acknowledgements
This study was supported by the Intramural Program of the National
InstituteonAging,NationalInstitutesofHealthandDepartmentofHealth
and Human Services, project number AG000950-07. This study used
high-performance computational capabilities of the Biowulf Systems at
the National Institutes of Health, Bethesda, MD (http://helix.nih.gov).
Conﬂict of interest
The authors declare that they have no conﬂict of interest.
References
Clarimo ´n J, Djaldetti R, Lleo ´ A, Guerreiro RJ, Molinuevo JL,
Paisa ´n-Ruiz C, Go ´mez-Isla T, Blesa R, Singleton A, Hardy J (2008)
Table I List of candidate loci associated with AD from the 22 autosome of the AD SNP genotype data (Coon et al, 2007)
CHR SNP ID Location
a Function Gene Gene ID Effect
1 rs17325887
b,c 69998761 Intron LRRC7
d 57554 Risk
1 rs7520521
c 70020703 Intron LRRC7
d 57554 Risk
1 rs1913269
b,c 70052194 Intron LRRC7
d 57554 Risk
1 rs10754339
b 117491795 mRNA–UTR VTCN1
d 79679 Protect
1 rs16842422
b 196366613 –66918 LOC647195 647195 Protect
2 rs7582851 192032391 –392328 LOC647167 647167 Protect
3 rs6784615
b 52481466 Intron NISCH
d 11188 Protect
4 rs9994615 40786592 Intron APBB2
d 323 Risk
4 rs10015784
b 40793978 Intron APBB2
d 323 Risk
5 rs1602843
b,c 86324342 0 COL24A1
d 255631 Risk
5 rs2913719
b 163947773 2403 LOC440700 440700 Protect
6 rs13213247
b 81572755 –91974 LOC729817 729817 Risk
6 rs16892285 81592721 –72008 LOC729817 729817 Risk
6 rs13193950 81593433 –71296 LOC729817 729817 Risk
6 rs156232
b 104979509 481535 LOC642337 642337 Risk
10 rs10827687
b 36999313 –39887 GRIK3
d 2899 Risk
10 rs10824310
b 53698470 Intron PRKG1
d 5592 Risk
10 rs10740548 54877234 –2797 C1orf175
d 374977 Risk
11 rs1038891
b,c 40895642 0 RIMS3
d 9783 Risk
12 rs1354470
b 59088188 –32939 LOC645757 645757 Risk
12 rs7967572 73396068 51514 KRT8P21 126811 Risk
18 rs1785928
b 31979929 Coding non-synonymous ELP2
d 55250 Risk
19 rs11879589 50065116 Intron PVRL2
d 5819 Protect
19 rs4420638
b 50114786 Locus region APOC1
d 341 Protect
19
e 50150075
19 rs204907 50153836 Intron CLPTM1
d 1209 Protect
aIn nucleotide basepair.
bLoci remained in the model on logistic regression selection with a P-valueo0.05.
cLoci in homozygous regions containing candidate loci of recessive genetic lesion causing AD (Clarimo ´n et al, 2008).
dGenes are on known functional pathways and networks as revealed by the use of Ingenuity Pathway Analysis (Ingenuity Systems, www.ingenuity.com).
eA SNP in Affymetrix 500K GeneChip, but without NCBI ID.
Algorithm for genome-wide homozygosity analysis
W Liu et al
& 2009 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2009 5Whole genome analysis in a consanguineous family with early
onset Alzheimer’s disease. Neurobiol Aging, doi:10.1016/
j.neurobiolaging.2008.02.008
Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, Hu Lince D,
Zismann VL, Beach TG, Leung D, Bryden L, Halperin RF, Marlowe
L, Kaleem M, Walker DG, Ravid R, Heward CB, Rogers J,
Papassotiropoulos A, Reiman EM, Hardy J et al. (2007) A high-
density whole-genome association study reveals that APOE is the
major susceptibility gene for sporadic late-onset Alzheimer0s
disease. J Clin Psychiatry 68: 613–618
Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R,
MyersRH,Pericak-VanceMA,RischN,vanDuijnCM(1997)Effects
ofage,sex,andethnicityontheassociationbetweenapolipoprotein
E genotype and Alzheimer disease. A meta-analysis. APOE and
Alzheimer Disease Meta Analysis Consortium. J Am Med Assoc
278: 1349–1356
Gschwend M, Levran O, Kruglyak L, Ranade K, Verlander PC,
Shen S, Faure S, Weissenbach J, Altay C, Lander ES, Auerbach
AD, Botstein D (1996) A locus for Fanconi anemia on 16q
determined by homozygosity mapping. Am J Hum Genet 59:
377–384
Gunderson KL, Steemers FJ, Lee G, Mendoza LG, Chee MS (2005) A
genome-wide scalable SNP genotyping assay using microarray
technology. Nat Genet 37: 549–554
Hinds DA, Stuve LL, Nilsen GB, Halperin E, Eskin E, Ballinger DG,
Frazer KA, Cox DR (2005) Whole-genome patterns of
common DNA variation in three human populations. Science 307:
1072–1079
Hunter DJ (2005) Gene–environment interactions in human diseases.
Nat Rev Genet 6: 287–298
KleinRJ,ZeissC, ChewEY,Tsai JY,SacklerRS,HaynesC, HenningAK,
SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J,
Barnstable C, Hoh J (2005) Complement factor H polymorphism in
age-related macular degeneration. Science 308: 385–389
Lander ES, Botstein D (1987) Homozygosity mapping: a way to map
human recessive traits with the DNA of inbred children. Science
236: 1567–1570
Laws SM, Hone E, Gand S, Martins RN (2003) Expanding the
association between the APOE gene and the risk of Alzheimer0s
disease: possible roles for APOE promoter polymorphisms and
alterations in APOE transcription. J Neurochem 84: 1215–1236
Lencz T, Lamberta C, DeRosse P, Burdick K, Morgan TV, Kane JM,
Kucherlapati R, Malhotra AK (2007) Runs of homozygosity reveal
highly penetrant recessive loci in schizophrenia. Proc Natl Acad Sci
USA 100: 9440–9445
Miyazawa H, Kato H, Awata T, Kohda M, Iwasa H, Koyama N, Tanaka
T, Huqun, Kyo S, Okazaki Y, Hagiwara K (2007) Homozygosity
haplotype allows a genome-wide search for the autosomal
segments shared among patients. Am J Hum Genet 80: 1090–1102
Mueller RF, Bishop DT (1993) Autozygosity mapping, complex
consanguinity, and autosomal recessive disorders. J Med Genet
30: 798–799
Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S
(1993) Apolipoprotein E polymorphism and Alzheimer0s disease.
Lancet 342: 697–699
RabbeeN,SpeedTP(2006)Agenotypecallingalgorithmforaffymetrix
SNP arrays. Bioinformatics 22: 7–12
Simon-Sanches J, Scholz S, Fung HC, Matarin M, Hernandez D, Gibbs
JR, Britton A, Wavrant de Brieze F, Peckham E, Gwinn-Hardy K,
Crawley A, Keen JC, Nash J, Borgaonkar D, Hardy J, Singleton A
(2007) Genome-wide SNP assay reveals structural genomic
variation, extended homozygosity and cell-line induced
alterations in normal individuals. Hum Mol Genet 16: 1–14
Steemers FJ, Gunderson KL (2007) Whole genome genotyping
technologies on the BeadArray platform. Biotechnol J 2: 41–49
Wang K, Li M, Hadley D, Liu R, Glessner J, Grant S, Hakonarson H,
Bucan M (2007) PennCNV: an integrated hidden Markov model
designed for high-resolution copy number variation detection in
whole-genome SNP genotyping data. Genome Res 17: 1665–1674
Woods CG, Valente EM, Bond J, Roberts E (2004) A new method for
autozygosity mapping using single nucleotide polymorphisms
(SNPs) and EXCLUDEAR. J Med Genet 41: e101
Van Eyken E, Van Camp G, Van Laer L (2007) The complexity of age-
related hearing impairment: contributing environmental and
genetic factors. Audiol Neurootol 12: 345–358
MolecularSystemsBiologyisanopen-accessjournal
publishedbyEuropeanMolecularBiologyOrganiza-
tion and Nature Publishing Group.
This article is licensed under a Creative Commons Attribution-
Noncommercial-Share Alike 3.0 Licence.
Algorithm for genome-wide homozygosity analysis
W Liu et al
6 Molecular Systems Biology 2009 & 2009 EMBO and Macmillan Publishers Limited